Loading...
 
Register Log In Login with facebook

Magnesium treats diabetes and cardiovascular problems – meta-analysis Feb 2017

Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis.

J Hum Nutr Diet. 2017 Oct;30(5):621-633. doi: 10.1111/jhn.12454. Epub 2017 Feb 2.
Verma H1,2,3, Garg R1,2.

VitaminDWiki Summary

Items in both categories Magnesium and Diabetes are listed here:

Items in both categories Magnesium and Cardiovascular are listed here:


 Download the PDF from SciHub via VitaminDWiki

 Download the excelent report on the study by Examine.com from VitaminDWiki
which has the following chart

Image
BACKGROUND:
Cardiovascular disorders remain the leading cause of death in type 2 diabetic patients. In the present study, a systematic review and a meta-analysis of randomised controlled trials (RCTs) were conducted aiming to evaluate the effect of magnesium supplementation on type 2 diabetes (T2D) associated cardiovascular risk factors in both diabetic and nondiabetic individuals.

METHODS:
PubMed, Scopus, Cochrane, Web of Science and Google Scholar databases were searched from inception to 30 June 2016 aiming to identify RCTs evaluating the effect of magnesium supplementation on T2D associated cardiovascular risk factors. The data were analysed using a random effect model with inverse variance methodology. Sensitivity analysis, risk of bias analysis, subgroup analysis, meta-regression and publication bias analysis were also conducted for the included studies using standard methods.

RESULTS:
Following magnesium supplementation, a significant improvement was observed in fasting plasma glucose (FPG) [weighted mean difference (WMD) = -4.641 mg dL-1 , 95% confidence interval (CI) = -7.602, -1.680, P = 0.002], high-density lipoprotein (HDL) (WMD = 3.197 mg dL-1 , 95% CI = 1.455, 4.938, P < 0.001), low-density lipoprotein (LDL) (WMD = -10.668 mg dL-1 , 95% CI = -19.108, -2.228, P = 0.013), plasma triglycerides (TG) (WMD = -15.323 mg dL-1 , 95% CI = -28.821, -1.826, P = 0.026) and systolic blood pressure (SBP) (WMD = -3.056 mmHg, 95% CI = -5.509, -0.603, P = 0.015). During subgroup analysis, a more beneficial effect of magnesium supplementation was observed in diabetic subjects with hypomagnesaemia.

CONCLUSIONS:
Magnesium supplementation can produce a favourable effect on FPG, HDL, LDL, TG and SBP. Therefore, magnesium supplementation may decrease the risk T2D associated cardiovascular diseases, although future large RCTs are needed for making robust guidelines for clinical practice.

© 2017 The British Dietetic Association Ltd.

Created by admin. Last Modification: Wednesday November 22, 2017 02:52:43 UTC by admin. (Version 6)

Attached files

ID Name Comment Uploaded Size Downloads
8760 Mg, Diabetes, and Heart.jpg admin 18 Nov, 2017 17:12 27.61 Kb 37
8759 EDR Mg and cardio.pdf admin 18 Nov, 2017 17:11 555.78 Kb 19
8758 Mg Diabetes, Cardio SciHub.pdf PDF 2017 admin 18 Nov, 2017 17:11 565.77 Kb 14
See any problem with this page? Report it to the webmaster.